Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexanian

Showing results (211-220 of 371) with videos related to

Pageof 38
Sort By:
Cancer Treatment Reports|June 1, 1982
Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group studyJ Bonnet, R Alexanian, S Salmon, et al.
Leukemia & Lymphoma|May 1, 1994
Intensive sequential therapy for VAD-resistant multiple myelomaM A Dimopoulos, D M Weber, J Hester, et al.
Blood|December 1, 1988
Prognostic factors with high-dose melphalan for refractory multiple myelomaB Barlogie, R Alexanian, L Smallwood, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 7, 2021
Guideline-Concordant Insulin Infusion Initiation Among Critically Ill Patients With SepsisNicholas A Bosch, Kathryn L Fantasia, Katherine L Modzelewski, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 21, 2021
Insulin Requirements in Patients With Type 2 Diabetes Undergoing Bariatric Surgery in the Inpatient Setting and Upon Discharge: A Single-Center Retrospective Analysis of Insulin Management StrategiesKamonkiat Wirunsawanya, Sanjita Chittimoju, Kathryn L Fantasia, et al.
Cancer|March 29, 2002
Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of boneRichard B Wilder, Chul S Ha, James D Cox, et al.
Canadian Journal of Physiology and Pharmacology|August 21, 2010
Endothelin signaling via guanine exchange factor C3G in renal glomerular mesangial cellsVictoriya A Rufanova, Anna Alexanian, Tammo Ostendorf, et al.
Bone Marrow Transplantation|July 5, 2001
High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemiaA Anagnostopoulos, M A Dimopoulos, A Aleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1994
Primary therapy of multiple myeloma with paclitaxel (taxol)M A Dimopoulos, S Arbuck, M Huber, et al.
Blood|September 1, 1987
High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myelomaB Barlogie, R Alexanian, K A Dicke, et al.
Pageof 38

Showing results (211-220 of 371) with videos related to

Sort By:
Pageof 38
Cancer Treatment Reports|June 1, 1982
Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group studyJ Bonnet, R Alexanian, S Salmon, et al.
Leukemia & Lymphoma|May 1, 1994
Intensive sequential therapy for VAD-resistant multiple myelomaM A Dimopoulos, D M Weber, J Hester, et al.
Blood|December 1, 1988
Prognostic factors with high-dose melphalan for refractory multiple myelomaB Barlogie, R Alexanian, L Smallwood, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 7, 2021
Guideline-Concordant Insulin Infusion Initiation Among Critically Ill Patients With SepsisNicholas A Bosch, Kathryn L Fantasia, Katherine L Modzelewski, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 21, 2021
Insulin Requirements in Patients With Type 2 Diabetes Undergoing Bariatric Surgery in the Inpatient Setting and Upon Discharge: A Single-Center Retrospective Analysis of Insulin Management StrategiesKamonkiat Wirunsawanya, Sanjita Chittimoju, Kathryn L Fantasia, et al.
Cancer|March 29, 2002
Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of boneRichard B Wilder, Chul S Ha, James D Cox, et al.
Canadian Journal of Physiology and Pharmacology|August 21, 2010
Endothelin signaling via guanine exchange factor C3G in renal glomerular mesangial cellsVictoriya A Rufanova, Anna Alexanian, Tammo Ostendorf, et al.
Bone Marrow Transplantation|July 5, 2001
High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemiaA Anagnostopoulos, M A Dimopoulos, A Aleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1994
Primary therapy of multiple myeloma with paclitaxel (taxol)M A Dimopoulos, S Arbuck, M Huber, et al.
Blood|September 1, 1987
High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myelomaB Barlogie, R Alexanian, K A Dicke, et al.
Pageof 38